imipenem, anhydrous has been researched along with Infection, Wound in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 6 (30.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 3 (15.00) | 2.80 |
Authors | Studies |
---|---|
Hatano, K; Ikeda, F; Nakai, T; Takeda, S; Wakai, Y | 1 |
Alanazi, AK; Almuhanna, Y; Alqasmi, MH; Alrouji, M; Asad, M; Joseph, B; Kuriri, FA | 1 |
Khaledi, A; Khorshidi, A; Mohammadzamani, Z; Moosavi, GA; Piroozmand, A; Shakerimoghaddam, A | 1 |
AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
Fu, Y; Huang, G; Peng, Y; Tang, C; Yang, Y | 1 |
Chen, CS; Chen, PL; Ko, WC; Tang, HJ; Tsai, PJ; Wu, CJ | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M | 1 |
Bonomo, RA; Cassone, M; Harmos, F; Hoffmann, R; Knappe, D; Kovalszky, I; Ostorhazi, E; Otvos, L; Rozgonyi, F; Szabo, D; Sztodola, A; Wade, JD | 1 |
Devidze, G; Jibladze, M; Kistauri, A | 1 |
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
Barnea, Y; Carmeli, Y; Dagan, S; Eren, R; Gat, A; Gur, E; Kuzmenko, B; Navon-Venezia, S; Neville, LF | 1 |
Kaku, M; Kanemitsu, K; Komatsu, M; Kunishima, H; Mitsutake, K; Miyasaka, T; Ohisa, Y; Tamai, K; Yanagisawa, H | 1 |
Eslami, G; Khorasani, G; Salehifar, E | 1 |
Andrade, R; Cabello, M; Clavijo, E; Lucena, M; Queipo de Llano, E | 1 |
Graziani, AL; MacGregor, RR; Sexton, DJ; Tobey, LE; Wlodaver, CG; Yangco, BG | 1 |
Cumberland, NS; Jones, KP | 1 |
Marier, RL | 1 |
Alpert, G; Bloh, AM; Campos, JM; Connor, E; Dagan, R; Plotkin, SA; Powell, KR | 1 |
3 trial(s) available for imipenem, anhydrous and Infection, Wound
Article | Year |
---|---|
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Twice daily intramuscular imipenem/cilastatin in the treatment of skin and soft tissue infections.
Topics: Abscess; Bacterial Infections; Cellulitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Injections, Intramuscular; Skin Diseases, Infectious; Wound Infection | 1991 |
Role of imipenem/cilastatin in the treatment of soft tissue infections.
Topics: Abscess; Adolescent; Adult; Aged; Bacterial Infections; Carbuncle; Cellulitis; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Furunculosis; Humans; Imipenem; Male; Middle Aged; Skin Ulcer; Thienamycins; Wound Infection | 1985 |
17 other study(ies) available for imipenem, anhydrous and Infection, Wound
Article | Year |
---|---|
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.
Topics: Animals; beta-Lactamases; Burns; Cephalosporins; Drug Resistance, Multiple, Bacterial; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections; Wound Infection | 2007 |
Antibacterial Activity of
Topics: Animals; Anti-Bacterial Agents; Clove Oil; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oils, Volatile; Rats; Syzygium; Wound Infection | 2022 |
Inhibitory effects of Cinnamaldehyde, Carvacrol, and honey on the expression of exoS and ampC genes in multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infections.
Topics: Acrolein; ADP Ribose Transferases; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Burns; Cymenes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Honey; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Infection | 2020 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burn Units; Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins; Wound Infection | 2017 |
A comparative study of clinical Aeromonas dhakensis and Aeromonas hydrophila isolates in southern Taiwan: A. dhakensis is more predominant and virulent.
Topics: Adult; Aeromonas; Aged; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ceftriaxone; Cell Survival; DNA Gyrase; DNA-Directed RNA Polymerases; Female; Fibroblasts; Gentamicins; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Prevalence; Sequence Analysis, DNA; Soft Tissue Infections; Survival Analysis; Taiwan; Wound Infection | 2014 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection | 2010 |
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Burns; Colistin; Disease Models, Animal; Female; Humans; Imipenem; Injections, Intramuscular; Mice; Peptides; Plasma; Treatment Outcome; Wound Infection | 2010 |
[The characteristics of various forms of complicated surgery infections of the diabetic foot syndrome and their antibacterial treatment].
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetic Foot; Drug Combinations; Female; Humans; Imipenem; Ischemia; Male; Middle Aged; Wound Infection | 2011 |
Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Topics: Animals; Anti-Bacterial Agents; Burns; Disease Models, Animal; Female; Flagellin; Imipenem; Immunoglobulin G; Immunotherapy; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Wound Healing; Wound Infection | 2006 |
In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Quality Control; Sputum; Wound Infection | 2007 |
Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Child; Ciprofloxacin; Citrobacter freundii; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas Infections; Wound Infection | 2008 |
Imipenem/cilastatin-associated hiccups.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Gentamicins; Hiccup; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Tibial Fractures; Wound Infection | 1992 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |
Imipenem/cilastatin for the treatment of infections in hospitalized children.
Topics: Arthritis, Infectious; Bacterial Infections; Cellulitis; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Escherichia coli Infections; Female; Haemophilus Infections; Hospitalization; Humans; Imipenem; Infant; Kidney Diseases; Lymphadenitis; Male; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thienamycins; Wound Infection | 1985 |